Related Experiment Video
Updated: Mar 25, 2026

10:55
Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
1.0K
Secondary myopathy due to systemic diseases
J Finsterer1, W N Löscher2, J Wanschitz2
1Krankenanstalt Rudolfstiftung, Vienna, Austria. fifigs1@yahoo.de.
Acta Neurologica Scandinavica
|February 27, 2016
Summary
Systemic diseases can cause secondary muscle disease with varied symptoms. Early diagnosis and treatment of the underlying cause are key for a good prognosis, though severe cases can be fatal.
Area of Science:
- Neurology
- Rheumatology
- Internal Medicine
Background:
- Systemic diseases frequently impact skeletal muscle function.
- Manifestations range from mild to severe, affecting single or multiple muscle groups.
Purpose of the Study:
- To review recent advances in managing muscle disease secondary to systemic conditions.
- To discuss diagnostic and therapeutic strategies for these complex cases.
Main Methods:
- Comprehensive literature review using MEDLINE and Current Contents.
- Analysis of search results for relevant studies on systemic diseases and muscle involvement.
Main Results:
- Secondary myopathies arise from infections, endocrine, metabolic, autoimmune, vascular, hematologic, and malignant disorders.
- Clinical presentations include myositis, myasthenia, rhabdomyolysis, and vasculitic myopathies.
- Diagnosis utilizes standard myopathy work-up; treatment focuses on the underlying cause and supportive care.
Conclusions:
- Secondary muscle involvement in systemic diseases requires prompt recognition and management.
- Prognosis is generally favorable when the primary systemic condition is treatable.
Keywords:
endocrine disordersimmunological diseaseinfectionsmalignancymusclemyastheniamyopathyrhabdomyolysissystem diseaseMore Related Videos
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
3.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.4K
Disorders of the Skeletal Muscle
2.3K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K
Myasthenia Gravis: Diagnostic Tests
3.1K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.1K
Cardiomyopathy I: Introduction and Classification
788
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
788
Myocarditis I: Introduction
560
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
560
Chemical Synapses
12.4K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.4K

